Fresh analysis indicates that patients who come off blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight far faster than those who stop conventional diet and exercise programs.
Findings released in a major medical journal demonstrates that while overweight people can lose about a fifth of their total mass while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing such medications need to be informed of the risk of quick rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery suggests a reversion to original mass in about 18 months.
Weighing Treatments
The study, which reviewed 37 of studies involving over 9,000 of patients, contrasted the results of GLP-1 agonists with other pills.
Scientists point out that people who lose weight through diet and exercise usually see a more gradual creep back—perhaps 0.1 kg a month—after stopping.
Explaining the Fast Regain
Experts believe the mechanism of the injections is key to understanding the amplified rebound.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Long-term administration of GLP-1 concentrations far above than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication leads to appetite is unsuppressed, making overeating much more probable."
A Lifelong Issue?
The NHS recommend the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
Professionals argue that, considering the likelihood of weight regain, the therapy might need to be life-long.
This view is supported by pharmaceutical companies, who say that the results "underscore the persistent nature of obesity," comparing it to managing conditions like diabetes.
User Experiences
Individuals who have stopped the jabs report a intense resurgence of hunger.
"I experienced a switch activating and you're instantly starving," recalled one woman.
The struggle is compounded if patients have not established sustainable dietary or behavioural modifications during therapy.
Significant Use
Recent estimates show that millions of people in the UK have tried these injections in the last 12 months, with desire being substantial.
- Adoption is higher among females than males.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
Finally, clinicians caution that while these medications are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits relies on ongoing behavioural support.
